DEFINITIVE Trial Reaches Major Milestone: All Centres Approved and More Than 50% Recruitment Achieved
Drug Farm to Present Ophthalmologic and CNS Findings from Phase 1b Study of First-in-Class ALPK1 Inhibitor DF-003 in ROSAH Syndrome at ARVO 2026
The Last Mile: A Story of Human Progress For a thousand years, commerce moved at the speed of human encounter. From medieval marketplaces to Victorian storefronts, from mail carriers to modern couriers, one fundamental constraint shaped all exchange: Continue Reading
